Cargando…
In Silico Design of a Chimeric Humanized L-asparaginase
Acute lymphoblastic leukemia (ALL) is the most common cancer among children worldwide, characterized by an overproduction of undifferentiated lymphoblasts in the bone marrow. The treatment of choice for this disease is the enzyme L-asparaginase (ASNase) from bacterial sources. ASNase hydrolyzes circ...
Autores principales: | Pedroso, Alejandro, Herrera Belén, Lisandra, Beltrán, Jorge F., Castillo, Rodrigo L., Pessoa, Adalberto, Pedroso, Enrique, Farías, Jorge G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144303/ https://www.ncbi.nlm.nih.gov/pubmed/37108713 http://dx.doi.org/10.3390/ijms24087550 |
Ejemplares similares
-
Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems
por: Lefin, Nicolás, et al.
Publicado: (2023) -
From Synthesis to Characterization of Site-Selective PEGylated Proteins
por: Belén, Lisandra Herrera, et al.
Publicado: (2019) -
Tackling Ischemic Reperfusion Injury With the Aid of Stem Cells and Tissue Engineering
por: Zamorano, Mauricio, et al.
Publicado: (2021) -
Peg-Grafted Liposomes for L-Asparaginase Encapsulation
por: de Souza Guimarães, Marina, et al.
Publicado: (2022) -
l-Asparaginase Type II from Fusarium proliferatum: Heterologous Expression and In Silico Analysis
por: Cardoso, Samuel Leite, et al.
Publicado: (2023)